|
Novel Treatment Approaches for Patients With Early-Stage Non-Small-Cell Lung Cancer
Lundi 19 Novembre 2007 - 13:55 - 1 année depuis - Cancérologie - Medscape cancérologie Although not yet practice changing, lung cancer data presented at the 2007 ASCO meeting have interesting implications for adjuvant strategies in the early disease setting. Medscape Hematology-Oncology |
|
Active Surveillance for Favorable-risk Prostate Cancer: Who, How and Why?
Lundi 19 Novembre 2007 - 10:00 - 1 année depuis - Cancérologie - Medscape cancérologie Active surveillance is an option for managing screen-detected, low-volume prostate cancer. Rationale for active surveillance, patient selection criteria, and indications for intervention are reviewed. Nature Clinical Practice Oncology |
|
X-Ray Screening Reduces Gastric Cancer Mortality in Costa Rica
Lundi 19 Novembre 2007 - 09:19 - 1 année depuis - Cancérologie - Medscape cancérologie X-ray screening is associated with a halving of gastric cancer mortality in a community in Costa Rica, according to a report in the October 2nd issue of the British Journal of Cancer. Reuters Health Information |
|
Tamoxifen Superior to Arzoxifene for Locally Advanced or Metastatic Breast Cancer
Lundi 19 Novembre 2007 - 09:15 - 1 année depuis - Cancérologie - Medscape cancérologie Compared with arzoxifene, tamoxifen provides longer progression-free survival and time to treatment failure in women with locally advanced and metastatic breast cancer, according to a report in the November 1st Journal of Clinical Oncology. Reuters Health Information |
|
EU OKs Treatment With Merck's Ivemend, Isentress
Lundi 19 Novembre 2007 - 09:10 - 1 année depuis - Cancérologie - Medscape cancérologie The European Medicines Agency on Friday recommended the use of Merck & Co Inc's Ivemend to help prevent chemotherapy-induced nausea and the use of Isentress for use in combination with other HIV treatments. Reuters Health Information |
|
Patients With Small Cell Carcinoma of the Prostate Have a Poor Outcome
Lundi 19 Novembre 2007 - 09:04 - 1 année depuis - Cancérologie - Medscape cancérologie The prognostic outcome is poor in patients with small cell carcinoma of the prostate, according to results of a study published in the October 15th issue of Cancer. Serum lactate dehydrogenase (LDH) and albumin levels at the time of diagnosis may be predictive of disease-related outcomes. Reuters Health Information |
|
International Approvals: Reclast, Dyloject, Tarceva
Lundi 19 Novembre 2007 - 09:02 - 1 année depuis - Cancérologie - Medscape cancérologie Canada has approved a new indication for zoledronic acid 5-mg infusion (Aclasta), the United Kingdom has approved a new formulation of diclofenac sodium injection (Dyloject), and Japan has approved erlotinib tablets. Medscape Medical News |
|
Picornavirus Promising Against Metastatic Cancer
Lundi 19 Novembre 2007 - 08:55 - 1 année depuis - Cancérologie - Medscape cancérologie The newly discovered native picornavirus Seneca Valley Virus-001 shows powerful and selective cytolytic action in tumor cell lines, researchers report in the November 7th issue of the Journal of the National Cancer Institute. Reuters Health Information |
|
Breast Cancer Radiotherapy Associated With Some Cardiac Changes
Lundi 19 Novembre 2007 - 08:52 - 1 année depuis - Cancérologie - Medscape cancérologie Current methods of radiotherapy (RT) for breast cancer possibly present some risk of cardiac toxicity, although its clinical relevance is uncertain, according to researchers. Reuters Health Information |
|
New Insights Into Molecular Mechanisms of Cisplatin DNA
Lundi 19 Novembre 2007 - 08:18 - 1 année depuis - Cancérologie - Medscape cancérologie Researchers identify how cells cope with damage caused by cisplatin during chemotherapy treatment, revealing that lesions in the DNA caused by cisplatin lead to stalling of the transcription machine and subsequent removal of the lesion. Medscape Medical News |
< 1 – 11 – 21 – 31 – 41 – 51 – 61 – 71 – 81 – 91 – 101 – 111 – 121 – 131 – 141 – 151 – 161 – 162 – 163 – 164 – 165 – 166 – 167 – 168 – 169 – 170 – 171 – 172 – 173 – 174 – 175 – 176 – 177 – 178 – 179 – 180 – 181 – 182 – 183 – 184 – 185 – 186 >


Le microbe n'est rien. Le terrain est tout.
-- Louis Pasteur